KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Accumulated Expenses: 2010-2014

Historic Accumulated Expenses for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $6.0 million.

  • Biocryst Pharmaceuticals' Accumulated Expenses rose 104.65% to $23.0 million in Q3 2015 from the same period last year, while for Sep 2015 it was $23.0 million, marking a year-over-year increase of 104.65%. This contributed to the annual value of $6.0 million for FY2014, which is 5.00% up from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Accumulated Expenses of $6.0 million as of FY2014, which was up 5.00% from $5.7 million recorded in FY2013.
  • Over the past 5 years, Biocryst Pharmaceuticals' Accumulated Expenses peaked at $17.3 million during FY2010, and registered a low of $5.7 million during FY2013.
  • For the 3-year period, Biocryst Pharmaceuticals' Accumulated Expenses averaged around $7.2 million, with its median value being $6.0 million (2014).
  • Per our database at Business Quant, Biocryst Pharmaceuticals' Accumulated Expenses plummeted by 41.76% in 2013 and then increased by 5.00% in 2014.
  • Over the past 5 years, Biocryst Pharmaceuticals' Accumulated Expenses (Yearly) stood at $17.3 million in 2010, then decreased by 27.08% to $12.6 million in 2011, then fell by 21.85% to $9.9 million in 2012, then plummeted by 41.76% to $5.7 million in 2013, then rose by 5.00% to $6.0 million in 2014.